B
엠아이텍
179290KOSDAQ67.5 / 100
Reference Date: 2026-10-23
Financial Score37.0 / 40
News Sentiment12.5 / 25
Momentum8.0 / 20
Disclosure10.0 / 15
AI Analysis: the debt ratio is very low with excellent financial health and PER is significantly undervalued vs. peers is also solid. Declined 12.8% over the past month, with no recent news.
Company InformationBased on 2025 Annual Report
Business Overview
MITEC is a company that pioneered the development of non-vascular stents in South Korea, expanding its product portfolio and exporting to overseas markets. It obtained CE MDR certification in 2023 to enter the European market and is expanding its presence in the endoscopy sector by distributing Fujifilm endoscopy equipment.
Number of Employees
179people
Average Salary
52.7M KRW
Score Calculation Basis
Detailed Financial Score
PER
6.73Industry Average 15.008.0Point
Half of industry avg (excellent)
PBR
1.09Industry Average 1.204.0Point
In line with industry avg
ROE
17.32Industry Average 8.007.0Point
2.2x industry avg (excellent)
Debt Ratio
5.27Industry Average 100.008.0Point
Half of industry avg (excellent)
Trend 2023~202510.0 / 10 points
Revenue Growth Rate
3.0 / 3
Avg ▲20.4% (2-year basis)
Operating Profit Growth Rate
3.0 / 3
Avg ▲21.3% (2-year basis)
ROE Trend
4.0 / 4
Avg ROE 16.7% (improving, 3yr)
Detailed News Sentiment
0 totalPositive 0Neutral 0Negative 0
Detailed Momentum
52-week position1.0Point
Near 52w low (0%, downtrend)
Current 4,230Won52-week high 7,81052-week low 4,195
1-month return1.0Point
1m -12.78% (falling)
Volume trend6.0Point
Volume increasing
Detailed Disclosure
1 totalPositive 0Neutral 1Negative 0
- Neutral[기재정정]타법인주식및출자증권취득결정(자율공시)2026-09-28